Mountain Berg Ltd 3
3 · CONSTELLATION PHARMACEUTICALS INC · Filed Jul 18, 2018
Insider Transaction Report
Form 3
Mountain Berg Ltd
10% Owner
Holdings
Series E Preferred Stock
→ Common Stock (51,905 underlying)Series E-1 Preferred Stock
→ Common Stock (54,894 underlying)Series F Preferred Stock
→ Common Stock (68,127 underlying)
Footnotes (3)
- [F1]The Series E Preferred Stock is convertible into Common Stock on a 8.56256-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
- [F2]The Series E-1 Preferred Stock is convertible into Common Stock on a 11.009-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.
- [F3]The Series F Preferred Stock is convertible into Common Stock on a 11.009-for-one basis into the number of shares of Common Stock shown in Column 3 at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering without payment of further consideration. The shares have no expiration date.